Home » Topics » Regulatory

Regulatory
RSS

Amgen submits supplemental application with EMEA for anemia product

Oct. 26, 2001

Nonopioid analgesic effects reported for nitecapone and other COMT inhibitors

Oct. 25, 2001

Tipifarnib-based antitumor combinations extensively patented by Janssen

Oct. 24, 2001

Zometa will receive priority review for treatment of bone metastases

Oct. 24, 2001

Clinical trials of Remicade for congestive heart failure put on hold

Oct. 24, 2001

FDA grants expedited approval for Protonix I.V. in Zollinger-Ellison syndrome Rx

Oct. 24, 2001

Gleevec submitted for FDA review in gastrointestinal tumors

Oct. 24, 2001

Approval of Xeloda for treatment of breast cancer recommended in E.U.

Oct. 23, 2001

CPMP issues positive opinion regarding MabThera for treatment of aggressive NHL

Oct. 22, 2001

Once-daily Adderall XR approved by FDA for ADHD; registration trial discussed at CNS meeting

Oct. 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...